PDLI (PDL Biopharma) earnings beat estimates by one cent, and issues higher guidance. Revenues for 2006 projected to be about 10% than estimates. After a volatile up and down day, stock trades higher, over 31 after hours. Wooopaaah! Good news for the longs (including me).
link to Reuters summary
Company estimates 2006 earnings of 38 to 47 cents vs. 37 cent consensus. Even more impressive is the revenue guidance of $405 to $435 million vs. $378 million consensus.
No comments:
Post a Comment